Clopidogrel-aspirin

PreclinicalSmall molecule

YYuhan Corporation

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

P2Y12 InhibitorRecruiting

P2Y12 InhibitorPreclinical

Recruiting

Timeline

Expected Milestones

Q1 2027

Phase 3Active, not recruiting

Arteriosclerosis

NCT05047172

Q3 2027

N/ARecruiting

P2Y12 Inhibitor

NCT06714526

Q4 2029

Post-ApprovalNot yet recruiting

De-Escalation Therapy

NCT06763744

Clinical

Trials by Indication[1]

Tics2 trials

Comparative Pharmacokinetics of YH14659

Completed·YYuhan Corporation·Phase 1·NCT01422109·44 enrolled

Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects

Completed·YYuhan Corporation·Phase 1·NCT01657071·60 enrolled

Clopidogrel2 trials

PACT (Platelet Activity After Clopidogrel Termination)

Completed·UUniversity of Massachusetts, Worcester·N/A·NCT00619073·15 enrolled

Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration

Completed·DDong-A ST Co., Ltd.·Phase 1·NCT01526122·65 enrolled

Trial1 trial

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT00235248·350 enrolled

P2Y12 Inhibitor1 trial

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD

Recruiting·SSunnybrook Health Sciences Centre·N/A·NCT06714526·100 enrolled

Anticoagulant1 trial

Anticoagulant Treatments and Percutaneous Coronary Angioplasty

Terminated·—·Phase 4·NCT00669149·99 enrolled

3 more indications

Type 2 Diabetic Patients1 trial

Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients

Completed·JJuan J Badimon·Phase 4·NCT01823510·20 enrolled

De-escalation Therapy1 trial

Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR

Not yet recruiting·SSamsung Medical Center·Phase 4·NCT06763744·3,000 enrolled

Arteriosclerosis1 trial

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)

Active, not recruiting·UUniversity of Florida·Phase 3·NCT05047172·1,683 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for Clopidogrel-aspirin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Clopidogrel-aspirin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Clopidogrel-aspirin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Yuhan Corporation company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: YYuhan Corporation